Hms Capital Management, LLC Abb Vie Inc. Put Options Transaction History

Hms Capital Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2019 Apr 24, 2019	SELL	$77.14 - $90.79 $77,140 - $90,790	-1,000 Closed	0 $0
Q4 2018 Jan 14, 2019	SELL	$77.85 - $96.01 $506,024 - $624,065	-6,500 Reduced 86.67%	1,000 $92,000
Q3 2018 Nov 02, 2018	BUY	$88.91 - $98.84 $151,147 - $168,028	1,700 Added 29.31%	7,500 $710,000
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $377,076 - $446,166	-4,200 Reduced 42.0%	5,800 $538,000
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $116,428 - $127,672	1,300 Added 14.94%	10,000 $967,000
Q2 2017 Aug 11, 2017	BUY	N/A	8,700	8,700 $631,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Hms Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hms Capital Management, LLC with notifications on news.